Literature DB >> 30105164

Camptocormia: Etiology, diagnosis, and treatment response.

Farwa Ali1, Joseph Y Matsumoto1, Anhar Hassan1.   

Abstract

BACKGROUND: We sought to determine the etiologies, diagnostic testing, and management of a retrospective cohort of patients with camptocormia evaluated at a single center.
METHODS: We reviewed medical records of all adult patients evaluated at Mayo Clinic Rochester with a diagnosis of camptocormia from 2000 to 2014. Demographic and clinical data were abstracted and analyzed.
RESULTS: There were 276 patients (58.0% male), with mean age at presentation of 68.6 (±12.7) years. An etiology was identified in 98.2%. The most common etiologies were idiopathic Parkinson disease (22.5%), idiopathic axial myopathy (14.1%), and degenerative joint disease without fixed deformity (13.0%). We also identified several rare causes of camptocormia. Investigations included spine imaging, needle and surface EMG, and muscle biopsy. Most patients received physical therapy and orthotic support with limited benefit. Limited improvement of camptocormia was seen where a treatable etiology was identified.
CONCLUSIONS: An etiology can be identified in almost all cases of camptocormia. Most cases are due to 3 common disorders: Parkinson disease, axial myopathy, and degenerative joint disease. A diagnostic and treatment algorithm is proposed.

Entities:  

Year:  2018        PMID: 30105164      PMCID: PMC6075991          DOI: 10.1212/CPJ.0000000000000453

Source DB:  PubMed          Journal:  Neurol Clin Pract        ISSN: 2163-0402


  32 in total

1.  Effect of deep brain subthalamic stimulation on camptocormia and postural abnormalities in idiopathic Parkinson's disease.

Authors:  Mark A Hellmann; Ruth Djaldetti; Zvi Israel; Eldad Melamed
Journal:  Mov Disord       Date:  2006-11       Impact factor: 10.338

2.  Injection of the iliopsoas muscle with botulinum toxin in camptocormia.

Authors:  Carlo Colosimo; Filippo Maria Salvatori
Journal:  Mov Disord       Date:  2009-01-30       Impact factor: 10.338

3.  Camptocormia as presenting sign in dementia with Lewy bodies.

Authors:  Natalia Gavrylova; Nadège Limousin; Jérémie Belin; Bertrand de Toffol; Julien Praline
Journal:  Clin Neurol Neurosurg       Date:  2013-09-20       Impact factor: 1.876

4.  Improvement in dystonic camptocormia following botulinum toxin injection to the external oblique muscle.

Authors:  Subhashie Wijemanne; Joohi Jimenez-Shahed
Journal:  Parkinsonism Relat Disord       Date:  2014-06-16       Impact factor: 4.891

5.  Immediate effect of spinal magnetic stimulation on camptocormia in Parkinson's disease.

Authors:  Yoshiharu Arii; Yuki Sawada; Kazuyuki Kawamura; Sayaka Miyake; Yasuo Taichi; Yuishin Izumi; Yukiko Kuroda; Toshio Inui; Ryuji Kaji; Takao Mitsui
Journal:  J Neurol Neurosurg Psychiatry       Date:  2014-04-29       Impact factor: 10.154

Review 6.  Radiation-induced camptocormia and dropped head syndrome: Review and case report of radiation-induced movement disorders.

Authors:  Clemens Seidel; Thomas Kuhnt; Rolf-Dieter Kortmann; Kathrin Hering
Journal:  Strahlenther Onkol       Date:  2015-06-14       Impact factor: 3.621

7.  Camptocormia as a clinical manifestation of polymyositis/systemic sclerosis overlap myositis associated with anti-Ku.

Authors:  Thierry Zenone; Nathalie Streichenberger; Marie Puget
Journal:  Rheumatol Int       Date:  2012-03-28       Impact factor: 2.631

8.  Long-term effect of repeated lidocaine injections into the external oblique for upper camptocormia in Parkinson's disease.

Authors:  Yoshihiko Furusawa; Yohei Mukai; Tomoya Kawazoe; Terunori Sano; Harumasa Nakamura; Chikako Sakamoto; Yasuyuki Iwata; Mizuki Wakita; Yasuhiro Nakata; Kohei Kamiya; Yoko Kobayashi; Takashi Sakamoto; Yoshihisa Takiyama; Miho Murata
Journal:  Parkinsonism Relat Disord       Date:  2012-10-05       Impact factor: 4.891

9.  Camptocormia, a new side effect of sodium valproate.

Authors:  S Kiuru; M Iivanainen
Journal:  Epilepsy Res       Date:  1987-07       Impact factor: 3.045

10.  Is camptocormia a primary muscular disease?

Authors:  M Laroche; M B Delisle; R Aziza; J Lagarrigue; B Mazieres
Journal:  Spine (Phila Pa 1976)       Date:  1995-05-01       Impact factor: 3.468

View more
  7 in total

1.  Palmitoylethanolamide/Luteolin as Adjuvant Therapy to Improve an Unusual Case of Camptocormia in a Patient with Parkinson's Disease: A Case Report.

Authors:  Stefania Brotini
Journal:  Innov Clin Neurosci       Date:  2021 Oct-Dec

Review 2.  Prevalence of axial postural abnormalities and their subtypes in Parkinson's disease: a systematic review and meta-analysis.

Authors:  Shuangshuang Cao; Yusha Cui; Jianing Jin; Fangfei Li; Xin Liu; Tao Feng
Journal:  J Neurol       Date:  2022-09-13       Impact factor: 6.682

Review 3.  Recent advancements in lateral trunk flexion in Parkinson disease.

Authors:  Hiroshi Kataoka; Kazuma Sugie
Journal:  Neurol Clin Pract       Date:  2019-02

4.  Camptocormia in idiopathic normal pressure hydrocephalus: a case report.

Authors:  Massimiliano Todisco; Francesca Valentino; Enrico Alfonsi; Giuseppe Cosentino
Journal:  Acta Neurol Belg       Date:  2021-04-03       Impact factor: 2.471

5.  An Unusual Cause of Camptocormia.

Authors:  Sahil Mehta; Rajender Kumar; Vivek Lal
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2019-02-13

6.  Camptocormia as a Novel Phenotype in a Heterozygous POLG2 Mutation.

Authors:  Diana Lehmann Urban; Leila Motlagh Scholle; Kerstin Alt; Albert C Ludolph; Angela Rosenbohm
Journal:  Diagnostics (Basel)       Date:  2020-01-26

7.  Botulinum Neurotoxin Injections in Childhood Opisthotonus.

Authors:  Mariam Hull; Mered Parnes; Joseph Jankovic
Journal:  Toxins (Basel)       Date:  2021-02-12       Impact factor: 4.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.